Literature DB >> 1525174

Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups.

H Lortat-Jacob1, J A Grimaud.   

Abstract

Interferon-gamma binds to the glycosaminoglycan part of basement membrane proteoglycan. To obtain a greater insight into this interaction, different glycosaminoglycans and their subfractions were used in various binding assays. High affinity binding occurs with heparin and heparan sulfate only, the latter being the predominant basement membrane glycosaminoglycan. Furthermore, using heparan sulfate and heparin treated with heparinases I and III, we have shown that the interferon-gamma binding sites are localized on the N-sulfated glucosamine rich domains of the molecule. Interestingly, interferon-gamma and fibroblast growth factor compete for the same binding domain on heparan sulfate, although they are unrelated proteins. This last point is discussed in the light of the conformational flexibility of the glycosaminoglycan molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1525174     DOI: 10.1016/0304-4165(92)90069-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  CD4 T-cells regulate angiogenesis and myogenesis.

Authors:  Brian J Kwee; Erica Budina; Alexander J Najibi; David J Mooney
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

2.  Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation.

Authors:  M S Douglas; S Ali; D A Rix; J G Zhang; J A Kirby
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

3.  Fibronectin and alpha5 integrin regulate keratinocyte cell cycling. A mechanism for increased fibronectin potentiation of T cell lymphokine-driven keratinocyte hyperproliferation in psoriasis.

Authors:  Z Bata-Csorgo; K D Cooper; K M Ting; J J Voorhees; C Hammerberg
Journal:  J Clin Invest       Date:  1998-04-01       Impact factor: 14.808

4.  Heparin inhibits IFN-gamma-induced fractalkine/CX3CL1 expression in human endothelial cells.

Authors:  Masaharu Hatakeyama; Tadaatsu Imaizumi; Wakako Tamo; Koji Yamashita; Hidemi Yoshida; Ikuo Fukuda; Kei Satoh
Journal:  Inflammation       Date:  2004-02       Impact factor: 4.092

5.  NMR characterization of the interaction between the C-terminal domain of interferon-gamma and heparin-derived oligosaccharides.

Authors:  Cécile Vanhaverbeke; Jean-Pierre Simorre; Rabia Sadir; Pierre Gans; Hugues Lortat-Jacob
Journal:  Biochem J       Date:  2004-11-15       Impact factor: 3.857

6.  Interferon effect on glycosaminoglycans in mouse glioma in vitro.

Authors:  M Wiranowska; A K Naidu
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

7.  Molecular organization of the interferon gamma-binding domain in heparan sulphate.

Authors:  H Lortat-Jacob; J E Turnbull; J A Grimaud
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

Review 8.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

Review 9.  N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19.

Authors:  Heidi N du Preez; Colleen Aldous; Hendrik G Kruger; Lin Johnson
Journal:  Adv Pharmacol Pharm Sci       Date:  2022-08-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.